Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypesMichela Boi, Giorgio Inghirami|Oncotarget|2016Cited by 24